Mgc Pharmaceuticals Share Discussion Threads

[zxie] 05/12/2022 07:13

announced in MGC Pharma's market release titled "Operations Update" on 20 October 2022, AMC Holdings, amended the terms of its US$1,000,000 order of ArtemiC(TM) Rescue, with the product to be delivered in a single shipment, and to be ready for immediate supply in the US owing to increasing demand.

[looneytune] 04/12/2022 21:49

Delivery of US$1 million order of ArtemiCTM
to AMC Holdings completed
Key Highlights:
• US$1,000,000 delivery of ArtemiCTM to US distribution partner AMC Holdings completed.
• The ArtemiCTM delivery is MGC Pharma’s largest delivery into the US market to date.
MGC Pharmaceuticals Ltd (‘MGC Pharma’ or ‘the Company’) a European based pharmaceutical company specialising in the production and development of plant inspired medicines, is pleased to announce that it has completed the delivery of its largest order of ArtemiCTM to US distribution and marketing partner, AMC Holdings Inc. (AMC).
Delivery to AMC Holdings
As announced in MGC Pharma’s market release titled “Operations Update” on 20 October 2022, AMC Holdings, amended the terms of its US$1,000,000 order of ArtemiCTM Rescue, with the product to be delivered in a single shipment, and to be ready for immediate supply in the US owing to increasing demand.
Delivery of this large consignment of ArtemiCTM has now been completed, marking the first substantial commercial delivery of the product under the AMC US supply and distribution agreement to date.
Brent W. Yessin of AMC commented, “AMC are excited to bring the first commercial order of ArtemiCTM into the US. It will be available both on-line and through independent pharmacies. Since the pandemic, the federal government has stopped paying for many treatments the cost burden has shifted to the individual states and consumers. With this change in policy AMC are pleased to be in a position offer the market a natural, plant based and clinically tested treatment option1”.
5 December 2022
ASX Code: MXC
LSE Code: MXC
--Ends—
Authorised for release by the Managing Director, for further information please contact:
MGC Pharmaceuticals Ltd
Roby Zomer
CEO & Managing Director [phone] [e-mail]
UK Financial and Corporate Advisor
Hannam & Partners
Rupert Fane / Nilesh Patel
[phone]
[e-mail] / [e-mail]
UK PR Advisors
Tavistock
Charles Vivian / Tim Pearson [phone] [e-mail]
1 [e-mail] | mgcpharma.co.uk
MGC Pharmaceuticals Ltd | 1202 Hay Street, West Perth, WA 6005 PO Box 1976, West Perth WA 6872
T: [phone]
MGC Pharmaceuticals Ltd
David Lim
Company Secretary [phone] [e-mail]
UK Broker
Turner Pope
Andy Thacker
[phone] [e-mail]

About MGC Pharma
MGC Pharmaceuticals Ltd (LSE: MXC, ASX: MXC) is a European based pharmecutical company, focused on developing and supplying accessible and ethically produced plant inspired medicines, combining in-house research with innovative technologies, with the goal of finding or producing treatments to for unmet medical conditions.
The Company’s founders and executives are key figures in the global pharmaceuticals industry and the core business strategy is to develop and supply high quality plant inspired medicines for the growing demand in the medical markets in Europe, North America and Australasia.
MGC Pharma has a robust development pipeline targeting two widespread medical conditions and has further products under development.
MGC Pharma has partnered with renowned institutions and academia to optimise the development of targeted plant inspired medicines, to be produced in the Company’s EU-GMP Certified manufacturing facilities.
MGC Pharma has a growing patient base in Australia, the UK, Brazil and Ireland and has a global distribution footprint via an extensive network of commercial partners meaning that it is poised to supply the global market.

[heatseek77] 02/12/2022 16:24

goldie - guess we’re his own country
Like said check facts Roby not from Slovenia 🤷

[goforgold1] 02/12/2022 08:26

You check companies he is registered with

[heatseek77] 02/12/2022 08:09

Goldilocks still thick, Roby from Israel yah so point isn't a point as per usual - taxi please

[looneytune] 02/12/2022 07:07

UK Regulatory (RNS & others)

TIDMMXC

RNS Number : 4086I

MGC Pharmaceuticals Limited

02 December 2022

MGC Pharmaceuticals Ltd.

MDPI publish peer reviewed academic paper on MGC Pharma research collaboration on the cytotoxic effects of Cannabidiol and Cannabigerol on Glioblastoma stem cells

2 December 2022

ASX, LSE: MXC

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based pharmaceutical company specialising in the production and development of plant inspired medicines, has had a peer reviewed academic paper entitled 'The Cytotoxic Effects of Cannabidiol and Cannabigerol on Glioblastoma Stem Cells May Mostly Involve GPR55 and TRPV1 Signalling' published by MDPI.

MDPI is the largest open access publisher of peer reviewed academic journals, publishing nearly 400 open access journals and the fifth largest publisher overall in terms of journal paper output. The article has been published as a Molecular Cancer Biology research paper.

The glioblastoma research in the publication is a collaboration between MGC Pharma and the National Institute of Biology, a leading research university in Slovenia [1] .

The research paper tests Cannabidiol (CBD) and Cannabigerol (CBG) extracts provided by MGC Pharmaceuticals, and their impact on Glioblastoma cells. The study finds that GPR55 and TRPV1 receptors are the best targets for the antagonistic cannabinoids CBD and CBG (in an optimised mixture) to eliminate Glioblastoma (GBM) stem cells.

This approach avoids using psychoactive tetrahydrocannabinol (THC), which is potentially harmful, particularly in older GBM patients, and should be further tested in animal experiments and clinical trials.

Glioblastoma is a fast growing and aggressive form of cancer, usually starting in the brain. Currently only 5-10% of glioblastoma patients live beyond five years following diagnosis [2] .

The article is open access and can be accessed at the following URL:



--Ends--

[fxl5] 30/11/2022 15:58

City takeover rumours for undervalued cannabis stocks, could be this or octp
Or both.

[goforgold1] 24/11/2022 13:21

This still going lol .

[hoder] 10/11/2022 14:43

Heatseek7710 Dec '21 - 15:06 - 46 of 156
0
whites I'd say mxc likely next GW imho, Oxford close second but longer term. Heavily invested in both fyi
Rumours are from very credible sources. I took a slice this morning.

Heatseek777 Jan '22 - 09:55 - 53 of 156
0 1 0
David looks like a leak to me 👍

[heatseek77] 09/11/2022 19:34

Spikey spikey Goldilocks 😂🤣

[goforgold1] 09/11/2022 17:45

This company should be investigated for Investor Fraud . It's so blatant

[goforgold1] 09/11/2022 17:39

Zero coming soon lol . If your buying this your crazy

[amaretto1] 09/11/2022 17:11

They should be accountable !!!Deep verge is another one ..Add VAL in the mix Email FCA